AU2019373948B2 — Apparatus to administer drugs to mechanically ventilated patients
Assigned to Chiesi Farmaceutici SpA · Expires 2023-11-16 · 3y expired
What this patent protects
An apparatus to administer drugs to mechanically ventilated patients, comprises: a mechanical ventilator (2), an artificial airway to be associated to a patient (P) and a ventilation circuit (3) connecting the mechanical ventilator (2) to the artificial airway. The ventilation ci…
USPTO Abstract
An apparatus to administer drugs to mechanically ventilated patients, comprises: a mechanical ventilator (2), an artificial airway to be associated to a patient (P) and a ventilation circuit (3) connecting the mechanical ventilator (2) to the artificial airway. The ventilation circuit (3) comprises: an inspiratory line (6), a dry powder inhaler (16) disposed in line on the inspiratory line (6) and a connector (33) operatively connected to the dry powder inhaler (16) and to the inspiratory line (6). The connector (33) comprises: a first duct (41) facing an outlet port (25) of the dry powder inhaler (16) and connected or configured to be connected to a tube section (45) of the inspiratory line (6) placed downstream the dry powder inhaler (16); a second duct (43) facing an air inlet port (28) of the dry powder inhaler (16) and connected or configured to be connected to a tube section (46) of the inspiratory line (6) placed upstream the dry powder inhaler (16).
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.